Lifecycle and Validation of Analytical Procedures FDA ICH and USP
| Date : Friday Dec 12, 2025 | Presented By : John Fetzer | ||
| Time : 1:00 PM EST | Event Type : Live Webinar | ||
| Duration : 60 minutes | Event Category : Pharmaceutical | ||
| Days Left : 2 Days | Order Form : Order Form | ||
For group or any booking support, contact: cs@educationsgrow.com + 1 (844) 240-7679 (US Toll Free)
The life cycle of an analytical method includes its design, development, validation (covering instrumental qualification, continuous performance verification, and method transfer), and finally, the retirement of the method along with archiving all related documentation. The lifetime of an analytical method may vary—sometimes it is temporary, while in other cases, long-term use may change due to expected shifts in sample composition, purpose, or operations.
Instead of developing separate methods for each stage of change, similar methods can be validated and applied. The requirements of the FDA and ICH related to this will also be addressed.
Learning Objectives:-
The goal is to design a methodology that remains valid without needing revalidation, even when changes occur in the method, sample, results (both qualitative and quantitative), or in the scope and use of those results.
Areas Covered in the Session:-
The principles and scope, apparatus and equipment, operating parameters, reagents and standards, sample preparation, control standards preparation, procedure, system suitability, calculations, and data reporting are all included.
Why Should You Attend?
Revalidation during a method’s intended period of use is often costly and time-consuming, but these efforts can sometimes be reduced or even avoided.
Who Will Benefit?
John C. Fetzer has over 30 years of experience in HPLC methods development. He has authored or co-authored over 50 peer-reviewed papers on iquid chromatography and has served on the editorial advisory boards of the Journal of Chromatography, Analytical Chemistry, and Analytical and Bioanalytical Chemistry.
| Event | Category | Speaker | Deatils |
|---|---|---|---|
| Analytical Method Development | Pharmaceutical | John E. Lincoln | View Event |
| FDA's New Software Validation Requirements | Pharmaceutical | John E. Lincoln | View Event |
| Human Factors/ Usability Studies following ISO 62366, the FDA Guidance and the new FDA Draft Guidance | Pharmaceutical | Edwin Wald Busser | View Event |